Prostate cancer: measuring PSA

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE

Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of Physicians

(2013) Amir Qaseem et al.   ANNALS OF INTERNAL MEDICINE

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2013) A. Horwich et al.   ANNALS OF ONCOLOGY

Population-based analysis of prostate-specific antigen (PSA) screening in younger men (

(2013) Weranja K.B. Ranasinghe et al.   BJU INTERNATIONAL

The Melbourne Consensus Statement on the early detection of prostate cancer

(2013) Declan G. Murphy et al.   BJU INTERNATIONAL

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prostate-Specific Antigen Changes As Surrogate for Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Second-Line Chemotherapy

(2013) Susan Halabi et al.   JOURNAL OF CLINICAL ONCOLOGY

Screening for prostate cancer in New Zealand general practice

(2013) Obertová Zuzana et al.   JOURNAL OF MEDICAL SCREENING

Prostate-Specific Antigen Screening Trials and Prostate Cancer Deaths: The Androgen Deprivation Connection

(2013) I. E. Haines et al.   JNCI-Journal of the National Cancer Institute

Early Detection of Prostate Cancer: AUA Guideline

(2013) H. Ballentine Carter et al.   JOURNAL OF UROLOGY

Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011

(2013) Sue M Evans et al.   MEDICAL JOURNAL OF AUSTRALIA

The Dilemma of a Rising Prostate-Specific Antigen Level After Local Therapy: What Are Our Options?

(2013) Nicholas G. Zaorsky et al.   SEMINARS IN ONCOLOGY

Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study

(2013) A. J. Vickers et al.   BMJ-British Medical Journal

Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion

(2012) Ethan Basch et al.   JOURNAL OF CLINICAL ONCOLOGY

Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up

(2012) G. L. Andriole et al.   JNCI-Journal of the National Cancer Institute

Prostate-Cancer Mortality at 11 Years of Follow-up

(2012) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Radical Prostatectomy versus Observation for Localized Prostate Cancer

(2012) Timothy J. Wilt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of prostate volume measured by transrectal ultrasound and magnetic resonance imaging: Is transrectal ultrasound suitable to determine which patients should undergo active surveillance?

(2012) Brian E. Weiss et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Screening for prostate cancer: an updated Cochrane systematic review

(2011) Dragan Ilic et al.   BJU INTERNATIONAL

Engrailed-2 (EN2): A Tumor Specific Urinary Biomarker for the Early Diagnosis of Prostate Cancer

(2011) R. Morgan et al.   CLINICAL CANCER RESEARCH

Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer

(2011) Andrew J. Armstrong et al.   EUROPEAN UROLOGY

Prediction Models: Revolutionary in Principle, But Do They Do More Good Than Harm?

(2011) Andrew J. Vickers   JOURNAL OF CLINICAL ONCOLOGY

An Empirical Evaluation of Guidelines on Prostate-specific Antigen Velocity in Prostate Cancer Detection

(2011) Andrew J. Vickers et al.   JNCI-Journal of the National Cancer Institute

Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer

(2011) Simpa S. Salami et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study

(2010) Anita V. Mitra et al.   BJU INTERNATIONAL

EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease

(2010) Axel Heidenreich et al.   EUROPEAN UROLOGY

[-2]Proenzyme Prostate Specific Antigen is More Accurate Than Total and Free Prostate Specific Antigen in Differentiating Prostate Cancer From Benign Disease in a Prospective Prostate Cancer Screening Study

(2010) Brian V. Le et al.   JOURNAL OF UROLOGY

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

(2010) Jonas Hugosson et al.   LANCET ONCOLOGY

Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer

(2009) Laurence Klotz et al.   JOURNAL OF CLINICAL ONCOLOGY

Prostate Cancer–Specific Survival Following Salvage Radiotherapy vs Observation in Men With Biochemical Recurrence After Radical Prostatectomy

(2008) Bruce J. Trock   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

(2008) Howard I. Scher et al.   JOURNAL OF CLINICAL ONCOLOGY

Systematic Review of Pretreatment Prostate-Specific Antigen Velocity and Doubling Time As Predictors for Prostate Cancer

(2008) Andrew J. Vickers et al.   JOURNAL OF CLINICAL ONCOLOGY

PCA3: A Molecular Urine Assay for Predicting Prostate Biopsy Outcome

(2008) Ina L. Deras et al.   JOURNAL OF UROLOGY

Predicting Prostate Cancer Risk Through Incorporation of Prostate Cancer Gene 3

(2008) Donna Pauler Ankerst et al.   JOURNAL OF UROLOGY